Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 USD | -6.40% | +2.15% | -32.39% |
May. 10 | First Wave BioPharma, Inc. announced a financing transaction | CI |
Mar. 29 | First Wave BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.01M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.65
x | P/E ratio 2025 * |
-1.92
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.98% |
1 day | -6.40% | ||
1 week | +2.15% | ||
Current month | +7.56% | ||
1 month | -13.16% | ||
3 months | -44.86% | ||
6 months | -47.26% | ||
Current year | -32.39% |
Managers | Title | Age | Since |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 19-10-07 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 22-02-28 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-03-02 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 15-04-30 |
Alastair Riddell
BRD | Director/Board Member | 74 | 15-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 2.84 | -4.39% | 35 712 |
24-05-14 | 2.97 | -0.67% | 38,268 |
24-05-13 | 2.99 | +4.91% | 19,354 |
24-05-10 | 2.85 | +1.06% | 26,775 |
24-05-09 | 2.82 | +1.44% | 5,232 |
Delayed Quote Nasdaq, May 15, 2024 at 02:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.39% | 6.01M | |
+29.47% | 49.18B | |
+0.99% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.59% | 26.09B | |
-22.72% | 18.71B | |
+8.46% | 13.26B | |
+32.07% | 12.32B | |
-0.85% | 11.99B |
- Stock Market
- Equities
- FWBI Stock